Author:
Syed Jamil S.,Javier-Desloges Juan,Tatzel Stephanie,Bhagat Ansh,Nguyen Kevin A.,Hwang Kevin,Kim Sarah,Sprenkle Preston C.
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Tosoian JJ, Carter HB, Lepor A, Loeb S. Active surveillance for prostate cancer: current evidence and contemporary state of practice. Nat Rev Urol. 2016;13(4):205–15.
2. Coen JJ, Feldman AS, Smith MR, Zietman AL. Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention? BJU Int. 2011;107(10):1582–6.
3. Ip S, Dahabreh IJ, Chung M, Yu WW, Balk EM, Iovin RC, et al. An evidence review of active surveillance in men with localized prostate cancer. Evid Rep Technol Assess. 2011;204:1–341.
4. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271(5):368–74.
5. Bastian PJ, Mangold LA, Epstein JI, Partin AW. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer. 2004;101(9):2001–5.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献